Table 5.
Markers | Spearman’s rho | p values | |
---|---|---|---|
CD3 | CD4 | 0.355* | 0.011 |
CD8 | 0.263 | 0.065 | |
CD56 | 0.156 | 0.279 | |
LAG3 | − 0.080 | 0.580 | |
TIM3 | 0.357* | 0.011 | |
PD-1 | 0.152 | 0.291 | |
PDL1 | 0.177 | 0.223 | |
CD4 | CD8 | 0.268 | 0.060 |
CD56 | 0.082 | 0.571 | |
LAG3 | 0.284* | 0.045 | |
TIM3 | 0.001 | 0.996 | |
PD-1 | 0.058 | 0.688 | |
PDL1 | − 0.093 | 0.525 | |
CD8 | CD56 | − 0.031 | 0.830 |
LAG3 | − 0.108 | 0.454 | |
TIM3 | 0.112 | 0.438 | |
PD-1 | 0.428* | 0.002 | |
PDL1 | 0.366* | 0.010 | |
CD56 | LAG3 | 0.144 | 0.317 |
TIM3 | − 0.022 | 0.878 | |
PD-1 | 0.288* | 0.042 | |
PDL1 | 0.285* | 0.047 | |
LAG3 | TIM3 | 0.152 | 0.292 |
PD-1 | 0.030 | 0.837 | |
PDL1 | − 0.128 | 0.382 | |
TIM3 | PD-1 | 0.211 | 0.141 |
PDL1 | 0.218 | 0.133 | |
PD-1 | PDL1 | 0.232 | 0.109 |
Spearman rho to determine correlation and p < 0.5 used to determine significance. *Significant results. All significant correlations were positive correlations